DK1501806T3 - Preparations for topical application of antiandrogenic active substances - Google Patents

Preparations for topical application of antiandrogenic active substances

Info

Publication number
DK1501806T3
DK1501806T3 DK03722464T DK03722464T DK1501806T3 DK 1501806 T3 DK1501806 T3 DK 1501806T3 DK 03722464 T DK03722464 T DK 03722464T DK 03722464 T DK03722464 T DK 03722464T DK 1501806 T3 DK1501806 T3 DK 1501806T3
Authority
DK
Denmark
Prior art keywords
preparations
active substances
topical application
antiandrogenic
antiandrogenic active
Prior art date
Application number
DK03722464T
Other languages
Danish (da)
Inventor
Wolfgang Mehnert
Monika Schaefer-Korting
Karl Theodor Kraemer
Karl-Heinz Nietsch
Rainer Pooth
Uwe Muenster
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1501806T3 publication Critical patent/DK1501806T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03722464T 2002-04-27 2003-04-14 Preparations for topical application of antiandrogenic active substances DK1501806T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10218963A DE10218963A1 (en) 2002-04-27 2002-04-27 Preparations for the topical application of antiandrogen active substances

Publications (1)

Publication Number Publication Date
DK1501806T3 true DK1501806T3 (en) 2006-05-29

Family

ID=29264882

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03722464T DK1501806T3 (en) 2002-04-27 2003-04-14 Preparations for topical application of antiandrogenic active substances

Country Status (17)

Country Link
EP (1) EP1501806B1 (en)
JP (1) JP4633459B2 (en)
AR (1) AR039662A1 (en)
AT (1) ATE321756T1 (en)
AU (1) AU2003229658B2 (en)
BR (1) BRPI0309579B8 (en)
CA (1) CA2483786C (en)
DE (2) DE10218963A1 (en)
DK (1) DK1501806T3 (en)
ES (1) ES2256735T3 (en)
IL (1) IL164814A0 (en)
MX (1) MXPA04009571A (en)
MY (1) MY129714A (en)
PE (1) PE20031044A1 (en)
PT (1) PT1501806E (en)
TW (1) TWI285637B (en)
WO (1) WO2003093243A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004111012A1 (en) 2003-06-12 2004-12-23 Chugai Seiyaku Kabushiki Kaisha Imidazolidine derivative
ATE502298T1 (en) 2003-12-19 2011-04-15 Univ California METHODS AND MATERIALS FOR ASSESSING PROSTATE CANCER THERAPIES
CN100475781C (en) * 2004-02-13 2009-04-08 沃尼尔·朗伯有限责任公司 Androgen receptor modulators
JP3997255B2 (en) * 2004-02-13 2007-10-24 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Androgen receptor modulator
AU2005232526B2 (en) 2004-02-24 2011-06-23 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US7507860B2 (en) 2004-04-13 2009-03-24 Pfizer Inc. Androgen modulators
WO2005102990A1 (en) 2004-04-22 2005-11-03 Warner-Lambert Company Llc Androgen modulators
BRPI0513020A (en) 2004-07-08 2008-04-22 Warner Lambert Co androgen modulators, their uses, pharmaceutical composition, topical pharmaceutical formulation and article of manufacture
ES2302229T3 (en) * 2004-08-31 2008-07-01 Warner-Lambert Company Llc ANDROGEN MODULATORS.
TW200724139A (en) * 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
EP3412290B1 (en) 2006-03-27 2021-03-03 The Regents of The University of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
CN101460467B (en) 2006-03-29 2012-09-19 加利福尼亚大学董事会 Diarylthiohydantoin compounds
JP5535925B2 (en) 2007-10-26 2014-07-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Diarylhydantoin compounds as androgen receptor modulators
SI3124481T1 (en) 2010-02-16 2018-06-29 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
RU2503446C2 (en) * 2012-02-07 2014-01-10 Алексей Валентинович Одинцов Hair growth product (versions) and methods of treating alopecia
MY180834A (en) 2012-09-26 2020-12-10 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
PL222631B1 (en) * 2012-11-14 2016-08-31 Gdański Univ Medyczny Pharmaceutical composition comprising Roxithromycin, method for manufacture and medical use of the composition and the medicinal product comprising a composition
WO2014078929A1 (en) * 2012-11-26 2014-05-30 Universidade Federal De Minas Gerais - Ufmg Topical formulation for the prevention and treatment of alopecia and for inhibiting hair growth
JOP20200097A1 (en) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc Androgen receptor modulator and uses thereof
CN103965112A (en) * 2014-05-13 2014-08-06 上海孚一生物科技有限公司 Compound with antiandrogen activity as well as preparation method and application of compound
TWI726969B (en) 2016-01-11 2021-05-11 比利時商健生藥品公司 Substituted thiohydantoin derivatives as androgen receptor antagonists
AU2018351714A1 (en) 2017-10-16 2020-04-30 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2693461B1 (en) * 1992-07-08 1994-09-02 Roussel Uclaf New substituted phenylimidazolidines, process for their preparation, their use as medicaments and the pharmaceutical compositions containing them.
AU726572B2 (en) * 1994-02-16 2000-11-09 Aventis Pharma S.A. Cosmetics or pharmaceutical compositions consisting of liposomes
FR2716110B1 (en) * 1994-02-16 1996-04-05 Roussel Uclaf Cosmetic or pharmaceutical compositions comprising liposomes.

Also Published As

Publication number Publication date
PE20031044A1 (en) 2004-02-09
ES2256735T3 (en) 2006-07-16
AU2003229658A1 (en) 2003-11-17
EP1501806B1 (en) 2006-03-29
CA2483786C (en) 2011-08-09
CA2483786A1 (en) 2003-11-13
AR039662A1 (en) 2005-03-02
MY129714A (en) 2007-04-30
AU2003229658B2 (en) 2010-07-29
BR0309579B1 (en) 2014-10-07
TW200407312A (en) 2004-05-16
EP1501806A1 (en) 2005-02-02
WO2003093243A1 (en) 2003-11-13
JP2005535584A (en) 2005-11-24
JP4633459B2 (en) 2011-02-16
MXPA04009571A (en) 2005-01-11
DE50302818D1 (en) 2006-05-18
BRPI0309579B8 (en) 2021-05-25
PT1501806E (en) 2006-06-30
ATE321756T1 (en) 2006-04-15
TWI285637B (en) 2007-08-21
IL164814A0 (en) 2005-12-18
DE10218963A1 (en) 2003-11-20
BR0309579A (en) 2005-03-01

Similar Documents

Publication Publication Date Title
DK1501806T3 (en) Preparations for topical application of antiandrogenic active substances
NO2015010I1 (en) Everolimus - see appendix for application
IS8584A (en) Topical preparations for virus protection
DK1494692T3 (en) Topical pharmaceutical compositions comprising proanthocyanidins, glycyrrhetinic acid and telmestein for the treatment of dermatitis
DK1326864T3 (en) Joined aryl or heteroaryl compounds as anti-inflammatory and analgesic agents
DK1485127T3 (en) Use of agents to treat inflammation
DK1362582T3 (en) Coated solid dosage form
DK2172205T3 (en) Pharmaceutical formulation consisting of lanthanum compounds
DK1567112T3 (en) Thiazolidine-4-ones to inhibit hYAK3 proteins
NO20035087D0 (en) Use of HMG fragment as anti-inflammatory agents
NO20033556D0 (en) Pharmaceutical preparations
ATE488224T1 (en) AEROSOL FORMULATIONS OF DIISOBUTYRYL APOMORPHINE
DK1147083T3 (en) Arylpiperazinyl-cyclohexylindole derivatives for the treatment of depression
NO20044916L (en) Preparations of sulfinylacetamide
DK1348473T3 (en) Element sets for assembly of structures
DK1840125T3 (en) Intermediates for the preparation of dioxane-2-alkylcarbamates
IS7715A (en) New modafinil pharmaceutical formulations
DE60324806D1 (en) Anti-inflammatory di- and trifluoropyridine compounds
DK1150991T3 (en) Preparations for the treatment of inflammatory reactions
DE60316954D1 (en) SHAMPOO COMPOSITIONS
DK1996744T3 (en) Methods of antimicrobial coating
NO20035328D0 (en) New compounds and preparations as catheps inhibitors
DE60335019D1 (en) TOPICAL SKIN PREPARATIONS
DK1197485T3 (en) Cyclobutenedione dione derivatives for the treatment of artherosclerosis
DK1503747T3 (en) Diclofenac-based composition for topical treatment of diseases